Effectiveness of shengxuexiaoban capsules combined with glucocorticoid therapy for immune thrombocytopenia: A meta-analysis

Meng-Yuan Ding, Bing Li, Meng Yang, Wen-Sheng Zhai, Chun-Dong Song, Jian Zhang, Qiu-Yue Zhang, Peng-Fei Li and Li-Ya Liu

PLOS ONE, 2022, vol. 17, issue 9, 1-12

Abstract: Objective: To evaluate the effectiveness of the Shengxuexiaoban Capsules combined with glucocorticoid therapy for immune thrombocytopenia (ITP). Methods: We collected randomized controlled trials (RCTs) using shengxuexiaoban capsules in combination with glucocorticoid to treat ITP by searching major Chinese and English electronic databases. The outcome indicators were the effective rate, recurrence rate, the number of platelets in the blood, recovery time of platelets, and adverse reactions. We used STATA 16.0 and RevMan 5.3 for meta-analysis and GRADE pro. for evidence quality evaluation. Results: A total of 27 RCTs were included in the meta-analysis, and the results showed a significant difference (all p

Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0275122 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 75122&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0275122

DOI: 10.1371/journal.pone.0275122

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().